Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$35.21 - $47.3 $4.89 Million - $6.57 Million
138,800 New
138,800 $5.89 Million
Q1 2022

May 17, 2022

SELL
$101.89 - $150.09 $3.52 Million - $5.18 Million
-34,500 Reduced 39.43%
53,000 $6.16 Million
Q4 2021

Feb 15, 2022

BUY
$118.18 - $153.21 $5.47 Million - $7.09 Million
46,300 Added 112.38%
87,500 $13.2 Million
Q3 2021

Nov 16, 2021

SELL
$93.51 - $129.4 $4.6 Million - $6.37 Million
-49,200 Reduced 54.42%
41,200 $4.92 Million
Q2 2021

Aug 16, 2021

SELL
$77.0 - $100.19 $2.12 Million - $2.76 Million
-27,500 Reduced 23.32%
90,400 $8.81 Million
Q1 2021

May 18, 2021

SELL
$81.28 - $104.34 $9.23 Million - $11.8 Million
-113,500 Reduced 49.05%
117,900 $10.4 Million
Q4 2020

Feb 17, 2021

SELL
$86.4 - $121.75 $4.71 Million - $6.64 Million
-54,500 Reduced 19.06%
231,400 $22.1 Million
Q3 2020

Nov 17, 2020

BUY
$95.43 - $116.09 $11.9 Million - $14.4 Million
124,300 Added 76.92%
285,900 $32.5 Million
Q2 2020

Aug 17, 2020

BUY
$60.05 - $98.92 $9.09 Million - $15 Million
151,400 Added 1484.31%
161,600 $16 Million
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $2.01 Million - $3.82 Million
-42,400 Reduced 80.61%
10,200 $656,000
Q4 2019

Feb 14, 2020

BUY
$53.13 - $71.19 $951,027 - $1.27 Million
17,900 Added 51.59%
52,600 $3.14 Million
Q3 2019

Nov 14, 2019

SELL
$57.11 - $73.3 $1.35 Million - $1.73 Million
-23,600 Reduced 40.48%
34,700 $2.05 Million
Q2 2019

Aug 15, 2019

BUY
$54.41 - $71.7 $1.14 Million - $1.5 Million
20,900 Added 55.88%
58,300 $3.76 Million
Q1 2019

May 16, 2019

BUY
$32.25 - $73.56 $1.03 Million - $2.35 Million
32,000 Added 592.59%
37,400 $2.38 Million
Q4 2018

Feb 15, 2019

BUY
$28.45 - $40.65 $153,630 - $219,510
5,400 New
5,400 $205,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.94B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.